These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 8866493

  • 41. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
    Aponso PM, Faull RL, Connor B.
    Neuroscience; 2008 Feb 19; 151(4):1142-53. PubMed ID: 18201835
    [Abstract] [Full Text] [Related]

  • 42. In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions.
    Chen MT, Morales M, Woodward DJ, Hoffer BJ, Janak PH.
    Exp Neurol; 2001 Sep 19; 171(1):72-83. PubMed ID: 11520122
    [Abstract] [Full Text] [Related]

  • 43. Influence of environment on the efficacy of intrastriatal dopaminergic grafts.
    Döbrössy MD, Le Moal M, Montaron MF, Abrous N.
    Exp Neurol; 2000 Sep 19; 165(1):172-83. PubMed ID: 10964496
    [Abstract] [Full Text] [Related]

  • 44. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C, Kirik D, Björklund A.
    Exp Neurol; 2000 Feb 19; 161(2):503-16. PubMed ID: 10686072
    [Abstract] [Full Text] [Related]

  • 45. Chronic treatment with levodopa and/or selegiline does not affect behavioral recovery induced by fetal ventral mesencephalic grafts in unilaterally 6-hydroxydopamine-lesioned rats.
    Adams CE, Hoffman AF, Hudson JL, Hoffer BJ, Boyson SJ.
    Exp Neurol; 1994 Dec 19; 130(2):261-8. PubMed ID: 7867755
    [Abstract] [Full Text] [Related]

  • 46. Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats.
    Palmer MR, Granholm AC, van Horne CG, Giardina KE, Freund RK, Moorhead JW, Gerhardt GA.
    Brain Res; 2001 Jan 26; 890(1):86-99. PubMed ID: 11164771
    [Abstract] [Full Text] [Related]

  • 47. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B, Kozlowski DA, Unnerstall JR, Elsworth JD, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2001 May 26; 169(1):83-95. PubMed ID: 11312561
    [Abstract] [Full Text] [Related]

  • 48. In vivo magnetic resonance imaging of embryonic neural grafts in a rat model of striatonigral degeneration (multiple system atrophy).
    Schocke MF, Waldner R, Puschban Z, Kolbitsch C, Seppi K, Scherfler C, Kremser C, Zschiegner F, Felber S, Poewe W, Wenning GK.
    Neuroimage; 2000 Aug 26; 12(2):209-18. PubMed ID: 10913326
    [Abstract] [Full Text] [Related]

  • 49. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
    Yuan H, Sarre S, Ebinger G, Michotte Y.
    Brain Res; 2004 Nov 05; 1026(1):95-107. PubMed ID: 15476701
    [Abstract] [Full Text] [Related]

  • 50. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA, Connor B, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2000 Nov 05; 166(1):1-15. PubMed ID: 11031079
    [Abstract] [Full Text] [Related]

  • 51. A sequential intrastriatal dopaminergic graft strategy in the rodent model for Parkinson's disease: implications for graft survival and targeting.
    Baker KA, Purdy MB, Sadi D, Mukhida K, Mendez I.
    Cell Transplant; 2002 Nov 05; 11(3):185-93. PubMed ID: 12075984
    [Abstract] [Full Text] [Related]

  • 52. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
    Cenci MA, Kalén P, Mandel RJ, Wictorin K, Björklund A.
    Neuroscience; 1992 Nov 05; 46(4):943-57. PubMed ID: 1347413
    [Abstract] [Full Text] [Related]

  • 53. Development of intracerebral dopaminergic grafts: a combined immunohistochemical and autoradiographic study of its time course and environmental influences.
    Abrous N, Guy J, Vigny A, Calas A, Le Moal M, Herman JP.
    J Comp Neurol; 1988 Jul 01; 273(1):26-41. PubMed ID: 3145292
    [Abstract] [Full Text] [Related]

  • 54. Olfactory ensheathing glial co-grafts improve functional recovery in rats with 6-OHDA lesions.
    Johansson S, Lee IH, Olson L, Spenger C.
    Brain; 2005 Dec 01; 128(Pt 12):2961-76. PubMed ID: 16251218
    [Abstract] [Full Text] [Related]

  • 55. Cholecystokinin facilitates methamphetamine-induced dopamine overflow in rat striatum and fetal ventral mesencephalic grafts.
    Wang Y, Perng SL, Lin JC, Tsao WL.
    Exp Neurol; 1994 Dec 01; 130(2):279-87. PubMed ID: 7867757
    [Abstract] [Full Text] [Related]

  • 56. Pig xenografts to the immunocompetent rat brain: Survival rates using distinct neurotoxic lesions in the nigrostriatal pathway and two rat strains.
    Robichon R, Jaafar A, Terqui M, Brachet P, Peschanski M.
    Exp Neurol; 2005 Aug 01; 194(2):333-40. PubMed ID: 16022861
    [Abstract] [Full Text] [Related]

  • 57. No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy).
    Waldner R, Puschban Z, Scherfler C, Seppi K, Jellinger K, Poewe W, Wenning GK.
    Neuroscience; 2001 Aug 01; 102(3):581-92. PubMed ID: 11226695
    [Abstract] [Full Text] [Related]

  • 58. Functional brain tissue transplantation: reversal of lesion-induced rotation by intraventricular substantia nigra and adrenal medulla grafts, with a note on intracranial retinal grafts.
    Freed WJ.
    Biol Psychiatry; 1983 Nov 01; 18(11):1205-67. PubMed ID: 6652162
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.